Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-01-27

Clinical Trial Update: Early BOTOX After Spinal Cord Injury [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating early administration of BOTOX (onabotulinumtoxinA) after spinal cord injury is currently enrolling by invitation at the University of…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botox (OnabotulinumtoxinA)

Snippet

Sponsor: University of Washington | Conditions: Spinal Cord Injuries | EARLY_Phase 1 | Status: ENROLLING_BY_INVITATION